Health Care · Pharmaceutical Preparations · OTC · CIK 1865494 · no price history on file
Price series unavailable — No prices available for IOBTQ in [1900-01-01, 2026-07-31]. This symbol may require bring-your-own-key (BYOK) data.
| Days to cover1.0d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
IOBTQ is not in the screener universe.
No return windows available for IOBTQ.
No risk analytics available for IOBTQ.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Ikarian Capital, LLC | 1.4M | $81,391 | — | +0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 451,852 | $26,524 | — | +0.0% |
| GSA CAPITAL PARTNERS LLP | 348,352 | $20,000 | — | new |
| MARSHALL WACE, LLP | 301,291 | $18,077 | — | −29.8% |
| XTX Topco Ltd | 265,792 | $15,602 | — | +1575.4% |
| MORGAN STANLEY | 206,215 | $12,105 | — | −61.8% |
| MILLENNIUM MANAGEMENT LLC | 194,158 | $11,397 | — | +40.0% |
| CITIGROUP INC | 72,495 | $4,255 | — | −35.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for IOBTQ.
